Trials / Completed
CompletedNCT03128372
Validation of Next Generation Cerebral and Tissue Oximeter
Validation of Next Generation INVOS NIRS Cerebral and Tissue Oximeter to Measure Cerebral and Somatic Tissue Oxygen Saturation in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Medtronic - MITG · Industry
- Sex
- All
- Age
- 18 Years – 46 Years
- Healthy volunteers
- Accepted
Summary
This is a validation study of a near-infrared spectroscopy (NIRS) device designed to measure the cerebral tissue oxygen saturation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Desaturation | The delivered gas mixture will be adjusted to decrease the displayed saturation of peripheral oxygen. Each desaturation steps are of approximately 5 minutes duration with reduction in pulse oximeter oxygen saturation from 100 to 70%. |
Timeline
- Start date
- 2017-05-22
- Primary completion
- 2017-07-19
- Completion
- 2017-07-19
- First posted
- 2017-04-25
- Last updated
- 2018-11-09
- Results posted
- 2018-11-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03128372. Inclusion in this directory is not an endorsement.